Cite
HARVARD Citation
Thatcher, N. et al. (n.d.). Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial. Lancet oncology. 16 (7), pp. 763-774. [Online].